Group One Trading
HZNP

Group One Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Group One Trading’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-641,700
Closed -$74.2M – 8520
2023
Q3 		$74.2M Buy
641,700
+114,900
+22% +$12.3M 0.25% 46
2023
Q2 		$54.2M Buy
526,800
+446,700
+558% +$47.1M 0.17% 67
2023
Q1 		$8.74M Sell
80,100
-299,500
-79% -$33.1M 0.03% 542
2022
Q4 		$43.2M Buy
379,600
+222,000
+141% +$18.4M 0.1% 175
2022
Q3 		$9.75M Buy
157,600
+24,500
+18% +$1.71M 0.02% 738
2022
Q2 		$10.6M Sell
133,100
-298,200
-69% -$28.2M 0.02% 798
2022
Q1 		$45.4M Buy
431,300
+352,200
+445% +$34.3M 0.04% 282
2021
Q4 		$8.52M Sell
79,100
-6,400
-7% -$698K 0.01% 1230
2021
Q3 		$9.37M Sell
85,500
-1,900
-2% -$197K 0.01% 1114
2021
Q2 		$8.18M Sell
87,400
-95,900
-52% -$8.83M 0.01% 1237
2021
Q1 		$16.9M Sell
183,300
-99,500
-35% -$8.4M 0.03% 631
2020
Q4 		$20.7M Buy
282,800
+161,400
+133% +$12M 0.04% 427
2020
Q3 		$9.43M Sell
121,400
-17,500
-13% -$1.2M 0.03% 553
2020
Q2 		$7.72M Buy
138,900
+42,400
+44% +$1.81M 0.04% 563
2020
Q1 		$2.86M Buy
96,500
+6,700
+7% +$227K 0.02% 822
2019
Q4 		$3.25M Buy
89,800
+4,000
+5% +$123K 0.02% 941
2019
Q3 		$2.34M Buy
85,800
+31,100
+57% +$804K 0.02% 1089
2019
Q2 		$1.32M Sell
54,700
-8,500
-13% -$216K 0.01% 1399
2019
Q1 		$1.67M Sell
63,200
-176,600
-74% -$4.18M 0.02% 1052
2018
Q4 		$4.69M Buy
239,800
+21,400
+10% +$419K 0.04% 542
2018
Q3 		$4.28M Buy
218,400
+147,500
+208% +$2.8M 0.03% 670
2018
Q2 		$1.17M Sell
70,900
-98,800
-58% -$1.51M 0.01% 1564
2018
Q1 		$2.41M Sell
169,700
-21,600
-11% -$319K 0.02% 881
2017
Q4 		$2.79M Buy
191,300
+73,100
+62% +$1.03M 0.02% 986
2017
Q3 		$1.5M Buy
118,200
+25,800
+28% +$328K 0.01% 1262
2017
Q2 		$1.1M Sell
92,400
-84,600
-48% -$1.05M 0.01% 1380
2017
Q1 		$2.62M Sell
177,000
-1,417,900
-89% -$23M 0.03% 700
2016
Q4 		$25.8M Buy
1,594,900
+1,296,500
+434% +$23.5M 0.25% 67
2016
Q3 		$5.41M Buy
298,400
+48,100
+19% +$940K 0.06% 384
2016
Q2 		$4.12M Buy
250,300
+135,600
+118% +$2.19M 0.05% 466
2016
Q1 		$1.9M Sell
114,700
-163,100
-59% -$2.85M 0.03% 798
2015
Q4 		$6.02M Sell
277,800
-181,200
-39% -$3.53M 0.07% 305
2015
Q3 		$9.1M Buy
459,000
+290,000
+172% +$9.16M 0.13% 176
2015
Q2 		$5.87M Sell
169,000
-47,600
-22% -$1.45M 0.08% 266
2015
Q1 		$5.63M Sell
216,600
-12,000
-5% -$220K 0.09% 221
2014
Q4 		$2.95M Sell
228,600
-58,800
-20% -$736K 0.04% 459
2014
Q3 		$3.53M Buy
287,400
+58,300
+25% +$677K 0.05% 419
2014
Q2 		$3.62M Sell
229,100
-47,100
-17% -$672K 0.06% 398
2014
Q1 		$4.18M Buy
276,200
+141,700
+105% +$1.6M 0.07% 292
2013
Q4 		$1.02M Buy
134,500
+60,800
+82% +$328K 0.02% 1084
2013
Q3 		$249K Sell
73,700
-29,500
-29% -$77.8K ﹤0.01% 2190
2013
Q2 		$254K Buy
+103,200
New +$248K 0.01% 1937

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Group One Trading's HZNP Position: Q4 2023 in Review

Group One Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 25,845 shares — an estimated $2.99M sold.

Group One Trading first reported a position in HZNP in Q2 2013 and held it in 29 quarters. The position peaked at $10.1M in Q1 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Group One Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 25,845 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.99M.
  • Group One Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 29 quarters.
  • Group One Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.1M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.